Press Releases

Oct 25, 2021
NOVATO, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D.
Read More
Displaying 1 - 10 of 44